CARDINAL HEALTH INC. v. JOSEPH POPPELL (And Vice Versa)

319 Ga. 670
CourtSupreme Court of Georgia
DecidedSeptember 4, 2024
DocketS24A0687, S24X0643
StatusPublished
Cited by1 cases

This text of 319 Ga. 670 (CARDINAL HEALTH INC. v. JOSEPH POPPELL (And Vice Versa)) is published on Counsel Stack Legal Research, covering Supreme Court of Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
CARDINAL HEALTH INC. v. JOSEPH POPPELL (And Vice Versa), 319 Ga. 670 (Ga. 2024).

Opinion

319 Ga. 670 FINAL COPY

S24A0687, S24X0643. POPPELL et al. v. CARDINAL HEALTH, INC. et al.; and vice versa.

MCMILLIAN, Justice.

The family members of individual drug abusers brought this

action against several wholesale distributors of prescription

medications, alleging that they distributed controlled substances in

violation of state and federal law, resulting in the family members’

injuries by the drug abusers. In Case No. S24A0687, the family

members (hereinafter “Appellants”) appeal from the final judgment

entered on the jury’s verdict in favor of the distributors (hereinafter

“Appellees”), arguing that the trial court committed reversible error

in denying Appellants’ motion for new trial, which contended that a

juror was dishonest during the selection process and introduced

extraneous prejudicial information during deliberations, and that

the trial court erred in refusing to instruct the jury on willful

blindness. In Case No. S24X0643, the distributors cross-appeal, arguing that in the event this Court vacates the judgment in the

main appeal, the Court should determine that Georgia’s Drug

Dealer Liability Act, OCGA § 51-1-46 (“DDLA”), is unconstitutional

in that it violates due process by imposing liability without requiring

any transactional nexus between a defendant’s conduct and a

plaintiff’s injury;1 that Appellees are “licensed practitioners” exempt

from liability under the DDLA; that Appellants’ allegations of

regulatory violations cannot support a DDLA claim; and the

physical-impact rule bars most of Appellants’ claims. In Case No.

S24A0687, we reject Appellants’ enumerations of error and

therefore affirm. Our holding makes it unnecessary to address the

distributors’ cross-appeal, so we dismiss Case No. S24X0643 as

moot. See Rockdale County v. U.S. Enterprises, Inc., 312 Ga. 752,

753 (865 SE2d 135) (2021).

1 This Court has exclusive jurisdiction over all cases in which the constitutionality of a law has been drawn into question, even if the question is raised in a cross-appeal. See Ga. Const. of 1983, Art. VI, Sec. VI, Par. II; State v. Mondor, 306 Ga. 338, 339 n.2 (830 SE2d 206) (2019) (recognizing that when the Court has subject matter jurisdiction over a cross-appeal, the Court has jurisdiction “over the whole case” (punctuation omitted)). 2 Appellants are 21 individuals who are the spouses, parents,

siblings, and/or children of individual drug abusers in and around

Glynn County whose drug addictions allegedly caused emotional

neglect and abuse that injured Appellants. Appellees are DEA-

registered, state-licensed wholesale distributors of prescription

medications, including controlled substances, who supplied those

drugs to pharmacies. In their complaint, Appellants alleged

violations of the DDLA (OCGA § 51-1-46) and the Georgia Racketeer

Influenced and Corrupt Organizations Act (OCGA § 16-14-1 et seq.),

and negligence and breach of duty by Appellees and certain

pharmacies.2 Generally, Appellants’ DDLA claims alleged that the

drug abusers who injured them became addicted to prescription

opioids as a result of Appellees’ failure to report suspicious orders of

controlled substances to pharmacies in the Glynn County area or to

halt shipments of those orders.

A jury trial was held between January 23 and March 1, 2023.

2 Before trial, Appellants dismissed their breach of duty claims and the

pharmacy defendants settled, and during trial, Appellants dismissed their negligence claims. 3 At trial, Appellants argued and attempted to show that Appellees

distributed controlled substances in violation of state and federal

law to pharmacies who used those drugs to fill thousands of invalid

prescriptions from “pill mill” doctors. Based on the evidence at trial,

Appellants argued that Appellees had an unspoken understanding

with those pharmacies to make money by supplying the controlled

substances to fill those prescriptions, resulting in their use by

individual drug abusers who injured Appellants in the course of

their drug abuse. According to Appellants, the evidence proved that

Appellees violated state and federal law by failing in their duties to

maintain effective controls against the diversion of the controlled

substances they distributed; by failing to conduct adequate due

diligence on their pharmacy customers; and by failing to identify,

report, and halt suspicious orders of controlled substances to those

pharmacies, including shipments to the pharmacies that dispensed

the controlled substances actually used by the individual drug

abusers who injured Appellants, deliberately ignoring numerous red

flags in order to continue shipping the suspicious orders.

4 Appellees, however, argued that the evidence showed that they

had created and maintained compliance and due diligence programs

to guard against diversion of controlled substances and that they

followed the directives from federal and state regulators about

tracking and reporting suspicious pharmacy orders. At the close of

Appellants’ case, Appellees moved for a directed verdict on the

grounds that the DDLA violates due process, that Appellees are

“licensed practitioner[s]” the DDLA expressly exempts from

liability, that the alleged regulatory violations do not support DDLA

claims, and that the physical-impact rule barred the claims of most

Appellants. The trial court summarily denied Appellees’ motion, and

the case was submitted to the jury.

On March 1, 2023, the jury returned a verdict that none of the

remaining defendants were liable as to any of the plaintiffs’ claims.

These appeals followed.

1. Appellants’ primary contentions concern whether a new

trial should be granted based on allegations that one of the jurors

(Juror S. T.) introduced extraneous prejudicial information into jury

5 deliberations or was dishonest during jury selection.

According to the representations in Appellants’ pleadings both

here and below, about a week after the verdict was rendered, the

jury foreperson contacted Appellants’ counsel to inform counsel of

alleged misconduct by Juror S. T. and provided an affidavit

describing the alleged misconduct. The foreperson’s affidavit,

executed six days after entry of the final judgment, averred that

during jury deliberations Juror S. T. told the jury that he knew

individual drug abuser Ethan Tindall, who testified at trial, as well

as Tindall’s family; that Juror S. T. “suggested” that he had engaged

in criminal activity with Tindall and his brother; that Juror S. T.

had been a bad person; that Juror S. T. said that the Tindalls are

bad people and that Tindall was still engaging in criminal activity;

and that Juror S. T. suggested that God had put him on the jury to

prevent people like Tindall’s family from recovering from this

lawsuit.

Appellants moved for a new trial based on the grounds that

Juror S. T. had introduced extraneous prejudicial information

6 during deliberations and that Juror S. T. had not been truthful

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
319 Ga. 670, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cardinal-health-inc-v-joseph-poppell-and-vice-versa-ga-2024.